...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Accelerated approval
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Thanks for straightening me out RVXoldtimer. I had forgetten about the Pfizer contribution and it was the TNBC trial I was referring to.

It's a good sign but many miles to go in what I am beginning to believe is a very competitive field. 

Also, thanks bear for the TNBC trial update. Things are progressing.

GLTA

Toinv

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply